Lufinity Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin. Luliconazole belongs to the imidazole class of antifungals and exhibits broad-spectrum activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately fungal cell death. Lufinity Cream is primarily used for conditions such as tinea corporis, tinea cruris, and tinea pedis. Its once-daily application enhances patient compliance while providing effective antifungal action. The cream formulation allows for easy topical application and rapid absorption with minimal systemic exposure. Clinical studies have demonstrated that Luliconazole 1% is well tolerated with a low incidence of adverse reactions, which may include mild local irritation, redness, or itching at the site of application. Lufinity Cream should be applied to the affected area and surrounding skin after cleansing and drying, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. Patients are advised to avoid contact with eyes and mucous membranes and to discontinue use if hypersensitivity occurs.